Filing Flows › Industrials › Scientific Industries (SCND)
Scientific Industries (SCND) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · Scientific Industries (SCND) Q2 2026 earnings results →
Q2 2026 Revenue up 36% year over year to $1.5M · 84¢ of every $1 of revenue lost · operating margin -86.6%
Scientific Industries made $1.5M in Q2 2026 (+36% Y/Y). Operating margin -86.6%, net loss $1.2M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.5M in Q2 2026, up 36% year over year and up 20% from the previous quarter.
Gross margin was 42.3%, up 7.5 points from Q2 2025. Operating costs exceeded revenue by $1.3M, an operating margin of -86.6%. Operating expenses fell 14% while revenue rose 36%. The quarter ended with a net loss of $1.2M, narrower than the previous quarter's $1.6M loss.
Operating cash flow was −$904K. Non-cash charges added back $51K of depreciation and amortization and $162K of share-based compensation. Working capital and other items added $116K. Capital expenditures of $8K exceeded it, leaving free cash flow of −$912K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 14, 2026 | $1.5M | +36% | -86.6% | −$1.2M | −$904K |
| Q1 2026 | 10-Q | May 15, 2026 | $1.2M | +30% | -135.9% | −$1.6M | −$994K |
| Q4 2025 | 10-K | Mar 31, 2026 | $1.6M | +27% | -150.9% | −$2.5M | −$3.8M |
| Q3 2025 | 10-Q | Nov 19, 2025 | $1.4M | +5% | -108.4% | $4.0M | — |
| Q2 2025 | 10-Q | Aug 19, 2025 | $2.3M | -12% | -66.3% | −$1.5M | −$1.4M |
| Q1 2025 | 10-Q | May 13, 2025 | $2.4M | -3% | -75.3% | −$1.8M | −$1.3M |
| Q4 2024 | 10-K | Mar 31, 2025 | $2.8M | +3% | -69.5% | −$1.9M | −$379K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Scientific Industries
General . Incorporated in 1954, Scientific Industries, Inc., a Delaware corporation (“SI” and along with its subsidiaries, the “Company”), is engaged in the design, manufacture, and marketing of standard benchtop laboratory equipment (“Benchtop Laboratory Equipment”), and through its wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc., a Delaware corporation (“SBHI”), the design, manufacture, and marketing of bioprocessing systems and products (“Bioprocessing Systems”). SBHI has two wholly-owned subsidiaries – Scientific Bioprocessing, Inc., a Delaware corporation (“SBI”), and aquila biolabs GmbH, a German corporation (“Aquila”). The Company’s products are used primarily for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries performing laboratory-scale research.
In its own words, from its 10-K, filed Mar 31, 2026.
Scientific Industries against its Laboratory Analytical Instruments peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +36% against the peers' median +5%. Operating margin: -86.6% against the peers' median 8.2%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| SCND Scientific Industries | Q2 2026 | $1.5M | +36% | -86.6% |
| A Agilent Technologies | Q3 FY26 | $1.9B | +8% | 23.6% |
| WAT Waters | Q3 2026 | $1.8B | +121% | 7.2% |
| AVTR Avantor | Q3 2026 | $1.7B | +5% | 8.2% |
| ILMN Illumina | Q3 2026 | $1.1B | +4% | 27.0% |
| MTD Mettler Toledo International | Q3 2026 | $1.1B | +6% | 27.4% |
| BRKR Bruker | Q3 2026 | $874M | +2% | -10.4% |
| RVTY Revvity | Q3 2026 | $729M | +4% | 10.6% |
| BIO Bio-Rad Laboratories | Q3 2026 | $656M | +0.5% | -7.6% |
Source: Scientific Industries 10-Q on SEC EDGAR · CIK 87802 · Laboratory Analytical Instruments
More on SCND
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results